ARCHIVES

Philadelphia Firm Wins CIDAC Award

This article is from The Cancer Letter archive.

Vol. 10 No. 32 | August 24, 1984

Download PDF Visit The Full Archive

Related Articles

NCI To Proceed With Guidelines Unless Board Strongly Disagree

May 9, 1980

FDA Designates Zometa For Priority Review.

November 30, 2001

NTP Board Approves Concept For New Mutagenesis Assays

January 1, 1988

DCPC Advisors Okay New Program Project Grants In Prevention

January 27, 1995

ASCO 2012: Michael Link’s Presidential Address, and the 2012 Award Winners

June 8, 2012

VEGF Levels Can Predict Tumor’s Resistance to Avastin

July 29, 2011